A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.
NCT01283256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 655
Last updated 2014-01-27
Summary
The purpose of this study is to evaluate the safety and efficacy of zonisamide in the treatment of adult patients with partial, generalized or combined seizures.
Conditions
- Partial, Generalized and Combined Seizures
Interventions
- DRUG
-
zonisamide
zonisamide 100mg tablets
Sponsors & Collaborators
-
Eisai Inc.
lead INDUSTRY
Principal Investigators
-
Amitabh Dash · Eisai Pharmaceuticals India Private limited
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-05-31
Countries
- India
Study Locations
More Related Trials
-
A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
NCT06967012 ·Status: RECRUITING ·Phase: PHASE4
-
Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
NCT00298818 ·Status: COMPLETED
-
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
NCT00693017 ·Status: TERMINATED ·Phase: PHASE3
-
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
NCT00292461 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug
NCT01630057 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label, Zonegran (Zonisamide) In Partial Onset Seizures
NCT00215592 ·Status: COMPLETED ·Phase: PHASE4
-
A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy
NCT00477295 ·Status: COMPLETED ·Phase: PHASE3
-
Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures
NCT00692003 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
NCT06534502 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate
NCT00713622 ·Status: COMPLETED ·Phase: PHASE4
-
A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)
NCT01830868 ·Status: COMPLETED
-
A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies
NCT00154076 ·Status: COMPLETED ·Phase: PHASE4
-
ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs
NCT00659958 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
NCT00056576 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization
NCT00165828 ·Status: TERMINATED ·Phase: PHASE4
-
Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy
NCT06374966 ·Status: NOT_YET_RECRUITING
-
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
NCT04252846 ·Status: COMPLETED
-
Low and High Dose Zonisamide in Children as Monotherapy
NCT01127165 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures
NCT00236860 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)
NCT05814523 ·Status: WITHDRAWN ·Phase: PHASE3
-
Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
NCT03678753 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older
NCT03836924 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236873 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS
NCT04557085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
NCT00740623 ·Status: COMPLETED ·Phase: PHASE3